University of Cambridge, United Kingdom (UCAM)

The third largest department in the Cambridge School of Clinical Medicine, the Department of Clinical Neurosciences ( hosts over 290 staff within 30 research groups focused on understanding the nervous system in health and disease. The aim is to harness this understanding to develop new treatments for incurable neurological and related disorders. The Department provides a rich environment for translational scientists, including groups led by both basic and clinical scientists spanning from the molecule through to neurons in networks, and the functioning brain and nervous system in health and disease. The Department promotes inter-disciplinary research at all levels, leveraging the opportunities available on Europe’s largest Biomedical Campus within one of the world’s leading Universities. The Department currently attracts in excess of £11 million grant funding annually, primarily from the Medical Research Council, Wellcome Trust, National Institute for Health Research, European Union and National Institutes of Health.

The infrastructure of the Department of Clinical Neurosciences includes the Wolfson Brain Imaging Centre whose 7T MR and PET MR facilities provide amongst the best integrated brain imaging facilities in Europe. The MRC-Mitochondrial Biology Unit (MBU), a world-recognized centre for the study of mitochondrial medicine and biology. The Department has strong collaborations within the School of Clinical Medicine (notably the Departments of Psychiatry and Paediatrics), the School of Biological Sciences (psychology and neuroscience/development) and the Physical Sciences (chemistry, engineering, mathematics and computing). 

The Cambridge PhD project within MMM was approved by REA in the proposal for MMM and is funded by UKRI under grant ref. EP/Y032470/1.